Literature DB >> 29204685

Methylene Blue Protects the Isolated Rat Lungs from Ischemia-Reperfusion Injury by Attenuating Mitochondrial Oxidative Damage.

Wen-Fang Tian1, Si Zeng2, Qiong Sheng1, Jun-Liang Chen1, Ping Weng1, Xiao-Tong Zhang1, Jia-Jia Yuan1, Qing-Feng Pang3, Zhi-Qiang Wang4.   

Abstract

INTRODUCTION: Impaired mitochondrial function is a key factor attributing to the lung ischemia reperfusion injury (LIRI). Methylene blue (MB) has been reported to attenuate brain and renal ischemia-reperfusion injury. We hypothesized that MB also could have a protective effect against LIRI by preventing mitochondrial oxidative damage.
METHODS: Isolated rat lungs were assigned to the following four groups (n = 6): a sham group: perfusion for 105 min without ischemia; I/R group: shutoff of perfusion and ventilation for 45 min followed by reperfusion for 60 min; and I/R + MB group and I/R + glutathione (GSH) group: 2 mg/kg MB or 4 μM glutathione were intraperitoneally administered for 2 h, and followed by 45 min of ischemia and 60 min of reperfusion.
RESULTS: MB lessened pulmonary dysfunction and severe histological injury induced by ischemia-reperfusion injury. MB reduced the production of reactive oxygen species and malondialdehyde and enhanced the activity of superoxide dismutase. MB also suppressed the opening of the mitochondrial permeability transition pore and partly preserved mitochondrial membrane potential. Moreover, MB inhibited the release of cytochrome c from the mitochondria into the cytosol and decreased apoptosis. Additionally, MB downregulated the mRNA expression levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-18).
CONCLUSION: MB protects the isolated rat lungs against ischemia-reperfusion injury by attenuating mitochondrial damage.

Entities:  

Keywords:  Isolated lung reperfusion; Lung ischemia–reperfusion injury; Methylene blue; Mitochondrial damage

Mesh:

Substances:

Year:  2017        PMID: 29204685     DOI: 10.1007/s00408-017-0072-8

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  35 in total

1.  Methylene blue attenuates pancreas ischemia-reperfusion (IR)-induced lung injury: a dose response study in a rat model.

Authors:  Avi A Weinbroum
Journal:  J Gastrointest Surg       Date:  2009-07-01       Impact factor: 3.452

Review 2.  Animal models of ex vivo lung perfusion as a platform for transplantation research.

Authors:  Kevin Nelson; Christopher Bobba; Samir Ghadiali; Don Hayes; Sylvester M Black; Bryan A Whitson
Journal:  World J Exp Med       Date:  2014-05-20

3.  Neuroprotective effects of bisperoxovanadium on cerebral ischemia by inflammation inhibition.

Authors:  Lun-Lin Mao; Dong-Lin Hao; Xiao-Wei Mao; Yuan-Feng Xu; Ting-Ting Huang; Bo-Na Wu; Li-Hui Wang
Journal:  Neurosci Lett       Date:  2015-06-30       Impact factor: 3.046

Review 4.  The mitochondrion as a key regulator of ischaemic tolerance and injury.

Authors:  Denis N Silachev; Egor Y Plotnikov; Irina B Pevzner; Ljubava D Zorova; Valentina A Babenko; Savva D Zorov; Vasily A Popkov; Stanislovas S Jankauskas; Valery P Zinchenko; Gennady T Sukhikh; Dmitry B Zorov
Journal:  Heart Lung Circ       Date:  2014-06-24       Impact factor: 2.975

5.  Comparison between cellular and acellular perfusates for ex vivo lung perfusion in a porcine model.

Authors:  Marius Roman; Olivera Gjorgjimajkoska; Desley Neil; Sukumaran Nair; Simon Colah; Jasvir Parmar; Steven Tsui
Journal:  J Heart Lung Transplant       Date:  2015-04-02       Impact factor: 10.247

Review 6.  Ischemia-reperfusion injury: beneficial effects of mesenchymal stromal cells.

Authors:  Naima Souidi; Meaghan Stolk; Martina Seifert
Journal:  Curr Opin Organ Transplant       Date:  2013-02       Impact factor: 2.640

7.  Reactive oxygen species induce swelling and cytochrome c release but not transmembrane depolarization in isolated rat brain mitochondria.

Authors:  María F Galindo; Joaquín Jordán; Carmen González-García; Valentín Ceña
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

Review 8.  Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions.

Authors:  Alexander V Ovechkin; David Lominadze; Kara C Sedoris; Tonya W Robinson; Suresh C Tyagi; Andrew M Roberts
Journal:  Arch Physiol Biochem       Date:  2007-02       Impact factor: 4.076

Review 9.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

Review 10.  Oxidative Stress and Lung Ischemia-Reperfusion Injury.

Authors:  Renata Salatti Ferrari; Cristiano Feijó Andrade
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

View more
  4 in total

Review 1.  Comparative Study Regarding the Properties of Methylene Blue and Proflavine and Their Optimal Concentrations for In Vitro and In Vivo Applications.

Authors:  Maria-Eliza Nedu; Mihaela Tertis; Cecilia Cristea; Alexandru Valentin Georgescu
Journal:  Diagnostics (Basel)       Date:  2020-04-15

Review 2.  Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation.

Authors:  Luodan Yang; Hannah Youngblood; Chongyun Wu; Quanguang Zhang
Journal:  Transl Neurodegener       Date:  2020-06-01       Impact factor: 8.014

Review 3.  Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies.

Authors:  Ricardo O S Soares; Daniele M Losada; Maria C Jordani; Paulo Évora; Orlando Castro-E-Silva
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

4.  Assessment of effects of methylene blue on intestinal ischemia and reperfusion in a rabbit model: hemodynamic, histological and immunohistochemical study.

Authors:  Juan Morgaz; Sergio Ventura; Pilar Muñoz-Rascón; Rocio Navarrete; José Pérez; María Del Mar Granados; José Andrés Fernández-Sarmiento; Juan Manuel Domínguez; Verónica Molina; Rafael J Gómez-Villamandos; Rafael Zafra
Journal:  BMC Vet Res       Date:  2020-02-12       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.